Coming Down the Pipeline: What's on the Horizon and How to Mitigate Your Plan's Exposure to Risk

Join us on September 13 to look at the historical impact of big-ticket specialty medications that are driving trend and learn what to look out for in the near future in terms of critical and/or costly new drugs entering the market. An expert industry consultant from Rx Connection, joined by Goodyear, will break it down and help you understand what tools are available to help reduce your plan’s exposure to these enormous costs.

This webinar will feature:

  • A look at how we got to a place where specialty drugs are dominating cost and trend
  • Tips on how to manage this trend and what to look out for with respect to vender management of specialty medications
  • Strategy development around total specialty cost, including your medical specialty claims
  • An overview of recent high-cost specialty and gene therapy launches making an impact


Jeff Post, R.Ph., Chief Clinical Officer, Rx Connection
Ryan J Seman, Director, Compensation, Benefits & Global Mobility, The Goodyear Tire and Rubber Company
Jeanie Hutchinson, Manager, Benefits, The Goodyear Tire & Rubber Company


Webinar Resources:

Webinar Recording 

Webinar Presentation 



David Washington
P: 2025583007

LinkedIn Twitter